BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Visa
V
|
+$333M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$265M |
| 3 |
Motorola Solutions
MSI
|
+$222M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$220M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$193M |
Top Sells
| 1 |
Apple
AAPL
|
+$251M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$196M |
| 3 |
Alibaba
BABA
|
+$193M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$130M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| 1 | Technology | 14.35% |
| 2 | Financials | 12.02% |
| 3 | Consumer Discretionary | 9.44% |
| 4 | Healthcare | 8.58% |
| 5 | Industrials | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Nu Skin
NUS
$587M
| $426K | ﹤0.01% |
10,017
+7,237
| +260% | +$308K |
|
1602
Myriad Genetics
MYGN
$689M
| $421K | ﹤0.01% |
14,718
+3,015
| +26% | +$86.3K |
|
1603
Lattice Semiconductor
LSCC
$9.16B
| $421K | ﹤0.01% |
23,041
+5,002
| +28% | +$91.5K |
|
1604
StoneCo
STNE
$5.09B
| $421K | ﹤0.01% |
12,096
+7,858
| +185% | +$273K |
|
1605
Simmons First National
SFNC
$2.86B
| $420K | ﹤0.01% |
16,868
+4,793
| +40% | +$119K |
|
|
UNVR
1606
DELISTED
Univar Solutions Inc.
UNVR
| $419K | ﹤0.01% |
20,206
+10,437
| +107% | +$217K |
|
1607
Fabrinet
FN
$12.8B
| $419K | ﹤0.01% |
8,005
+957
| +14% | +$50.1K |
|
|
UNIT
1608
Uniti Group
UNIT
$1.63B
| $418K | ﹤0.01% |
53,822
-22,007
| -29% | -$171K |
|
|
AAT
1609
American Assets Trust
AAT
$1.26B
| $418K | ﹤0.01% |
8,933
-12,264
| -58% | -$573K |
|
|
BECN
1610
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $418K | ﹤0.01% |
12,452
+3,260
| +35% | +$109K |
|
|
UCB
1611
United Community Banks, Inc.
UCB
$3.83B
| $418K | ﹤0.01% |
14,727
-26,371
| -64% | -$748K |
|
|
MYOK
1612
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $416K | ﹤0.01% |
7,983
+3,212
| +67% | +$168K |
|
|
ARGO
1613
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $415K | ﹤0.01% |
5,910
-138
| -2% | -$9.69K |
|
|
PTLA
1614
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $414K | ﹤0.01% |
15,443
+3,027
| +24% | +$81.2K |
|
|
PVG
1615
DELISTED
PRETIUM RESOURCES INC.
PVG
| $412K | ﹤0.01% |
35,835
+21,135
| +144% | +$243K |
|
1616
Rapid7
RPD
$1.26B
| $412K | ﹤0.01% |
9,087
+3,669
| +68% | +$167K |
|
|
IMMU
1617
DELISTED
Immunomedics Inc
IMMU
| $412K | ﹤0.01% |
31,070
+10,610
| +52% | +$141K |
|
1618
Chesapeake Utilities
CPK
$2.93B
| $411K | ﹤0.01% |
4,314
+475
| +12% | +$45.3K |
|
1619
NovaGold Resources
NG
$2.86B
| $410K | ﹤0.01% |
67,610
+37,845
| +127% | +$230K |
|
1620
Belden
BDC
$5.02B
| $410K | ﹤0.01% |
7,689
+627
| +9% | +$33.4K |
|
1621
EXL Service
EXLS
$6.88B
| $410K | ﹤0.01% |
30,595
+6,050
| +25% | +$81K |
|
1622
Medpace
MEDP
$14B
| $409K | ﹤0.01% |
4,865
+1,812
| +59% | +$152K |
|
1623
LCI Industries
LCII
$2.39B
| $408K | ﹤0.01% |
4,447
-3,525
| -44% | -$324K |
|
1624
Cleveland-Cliffs
CLF
$5.59B
| $408K | ﹤0.01% |
56,504
+12,739
| +29% | +$92K |
|
1625
Chart Industries
GTLS
$8.99B
| $406K | ﹤0.01% |
6,509
+1,253
| +24% | +$78.1K |
|